293 related articles for article (PubMed ID: 15163334)
1. Erythrocyte Na/K-ATPase is increased in subjects with subclinical hypothyroidism.
Nicolini G; Balzan S; Colzani R; Scarlattini M; Taddei MC; Iervasi G
Clin Endocrinol (Oxf); 2004 Jun; 60(6):705-10. PubMed ID: 15163334
[TBL] [Abstract][Full Text] [Related]
2. Platelet Na,K-adenosine triphosphatase as a tissue marker of hyperthyroidism.
Chan AY; Shinde R; Chow CC; Cockram CS; Swaminathan R
Metabolism; 2001 Dec; 50(12):1393-6. PubMed ID: 11735082
[TBL] [Abstract][Full Text] [Related]
3. Effects of fasting, refeeding, and fasting with T3 administration on Na-K,ATPase in rat skeletal muscle.
Matsumura M; Kuzuya N; Kawakami Y; Yamashita K
Metabolism; 1992 Sep; 41(9):995-9. PubMed ID: 1325595
[TBL] [Abstract][Full Text] [Related]
4. Assessment of sodium-potassium ATPase activity in human erythrocytes in vitro.
Lijnen P; Groeseneken D; Laermans M; Lommelen L; Piccart Y; Amery A
Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):417-21. PubMed ID: 6092796
[TBL] [Abstract][Full Text] [Related]
5. Presence of a functional TSH receptor on human erythrocytes.
Balzan S; Nicolini G; Forini F; Boni G; Del Carratore R; Nicolini A; Carpi A; Iervasi G
Biomed Pharmacother; 2007 Sep; 61(8):463-7. PubMed ID: 17570630
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.
Dasmahapatra A; Cohen MP; Grossman SD; Lasker N
J Clin Endocrinol Metab; 1985 Jul; 61(1):110-5. PubMed ID: 2987290
[TBL] [Abstract][Full Text] [Related]
7. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sodium content, sodium transport, ouabain binding capacity and Na+, K+-ATPase activity in lean and obese subjects.
Hawkins M; Whittaker J; Wales JK; Swaminathan R
Horm Metab Res; 1984 Jun; 16(6):282-5. PubMed ID: 6094324
[TBL] [Abstract][Full Text] [Related]
9. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
10. The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: the impact of the negative feedback mechanism.
Falaschi P; Martocchia A; Proietti A; D'Urso R; Gargano S; Culasso F; Rocco A
Neuro Endocrinol Lett; 2004 Aug; 25(4):292-6. PubMed ID: 15361820
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
12. Status of the red cell Na,K-pump in hyper- and hypothyroidism.
DeLuise M; Flier JS
Metabolism; 1983 Jan; 32(1):25-30. PubMed ID: 6294446
[TBL] [Abstract][Full Text] [Related]
13. Cation transport in intact erythrocytes of hyperthyroid patients: role of the NaK-ATPase pump.
Michels RC; Ober KP; Hennessy JF
Horm Metab Res; 1981 Nov; 13(11):635-8. PubMed ID: 6273279
[TBL] [Abstract][Full Text] [Related]
14. Effect of thyroid status on ouabain binding to the human lymphocyte.
Arnott RD; White R; Jerums G
J Clin Endocrinol Metab; 1982 Jun; 54(6):1150-6. PubMed ID: 6281292
[TBL] [Abstract][Full Text] [Related]
15. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
16. The effect of diet on ouabain binding to erythrocytes from obese subjects.
Ash KO; Smith JB; Kemp JW; Lynch MB; Moody FG; Raymond JL; McKnight MR; Williams RR
Clin Physiol Biochem; 1983; 1(6):293-9. PubMed ID: 6094078
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
Ogasawara H; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):329-39. PubMed ID: 2842203
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sodium fluxes, ouabain binding sites, and Na+,K(+)-ATPase activity in hyperthyroidism.
Arumanayagam M; MacDonald D; Cockram CS; Swaminathan R
Metabolism; 1990 Sep; 39(9):952-7. PubMed ID: 2168011
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
Cheng JT; Kahn T; Kaji DM
J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
[TBL] [Abstract][Full Text] [Related]
20. Changes in acetylcholinesterase, Na+,K+-ATPase, and Mg2+-ATPase activities in the frontal cortex and the hippocampus of hyper- and hypothyroid adult rats.
Carageorgiou H; Pantos C; Zarros A; Stolakis V; Mourouzis I; Cokkinos D; Tsakiris S
Metabolism; 2007 Aug; 56(8):1104-10. PubMed ID: 17618957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
